Journal Club

 

2012


An Evaluation of Environmental Decontamination With Hydrogen Peroxide Vapor for Reducing the Risk of Patient Acquisition of Multidrug-Resistant Organisms

17.12.2012 (Veronika Bättig)
Passaretti C. et al.: An Evaluation of Environmental Decontamination With Hydrogen Peroxide Vapor for Reducing the Risk of Patient Acquisition of Multidrug-Resistant Organisms
CID 56 27-35 2013

Serological Response to Treatment of Syphilis According to Disease Stage and HIV Status

10.12.2012 (Constantine Bloch)
Knaute DF. et al.: Serological Response to Treatment of Syphilis According to Disease Stage and HIV Status
CID 55 1615-1622

1) Co-formulated elvitegravir, cobicistat, emtricitabine and tenofovir versus co-formulated efavirenz, emtricitabine and tenofovir for initial treatment of HIV-1 infection: a randomized, double-blind, phase 3 trial, analysis of results after 48 weeks
2) Co-formulated elvitegravir, cobicistat, emtricitabine and tenofovir versus co-formulated ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir for initial treatment of HIV-1 infection: a randomized, double-blind, phase 3 trial, analysis of results after 48 weeks

3.12.12 (Luigia Elzi)
1) Paul E. Sax; 2) E. De Jesus: 1) Co-formulated elvitegravir, cobicistat, emtricitabine and tenofovir versus co-formulated efavirenz, emtricitabine and tenofovir for initial treatment of HIV-1 infection: a randomized, double-blind, phase 3 trial, analysis of results after 48 weeks
2) Co-formulated elvitegravir, cobicistat, emtricitabine and tenofovir versus co-formulated ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir for initial treatment of HIV-1 infection: a randomized, double-blind, phase 3 trial, analysis of results after 48 weeks

Lancet 379 1) 2439-48; 2) 2429-38

High Incidence of Renal Stones Among HIV-Infected Patients on Ritonavir-Boosted Atazanavir Than in Those Receiving Other Protease Inhibitor-Containing Antiretroviral Therapy

26.11.2012 (Danielle Vuichard Gysin)
Hamada Y. et al.: High Incidence of Renal Stones Among HIV-Infected Patients on Ritonavir-Boosted Atazanavir Than in Those Receiving Other Protease Inhibitor-Containing Antiretroviral Therapy
CID 55 1262-1268 2012

Bartonella henselae Prevalence in Domestic Cats in California: Risk Factors and Association between Bacteremia and Antibody Titers

19.11.12 (Barbara Jakopp)
Chomel et al.: Bartonella henselae Prevalence in Domestic Cats in California: Risk Factors and Association between Bacteremia and Antibody Titers
J Clin Microbiol 33 2445-2450 1995

Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K.pneumoniae

05.11.12 (D. Fasel)
Tumbarello M. et al: Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K.pneumoniae: Importance of Combination Therapy
CID 55, Oktober 943-950 2012

A Global Analysis of Mucormycosis in France: The RetroZygo Study (2005-2007)

22.10.2012 (Adrian Schibli)
F. Lanternier, O. Lortholary et al.: A Global Analysis of Mucormycosis in France: The RetroZygo Study (2005-2007)
CID 54 (Supplement 1) S35-S43 2012

Transmission dynamics of extended-spectrum beta-lactamase-producing Enterobacteriaceae in the tertiary care hospital and the household setting

15.10.12 (Esther Künzli)
Hilty M. et al.: Transmission dynamics of extended-spectrum beta-lactamase-producing Enterobacteriaceae in the tertiary care hospital and the household setting
CID 55 967-975 2012

Antiretroviral Treatment of Adult HIV Infection - 2012 Recommendations oft the International Antiviral Society-USA Panel

1.10.12 (Mario Kurz)
Thompson MA et al: Antiretroviral Treatment of Adult HIV Infection - 2012 Recommendations oft the International Antiviral Society-USA Panel
JAMA 308 387-402 2012

Early Surgery versus Conventional Treatment for Infective Endocarditis

10.09.2012 (Veronika Bättig)
Kang D.- H. et al.:Early Surgery versus Conventional Treatmentfor Infective Endocarditis
NEJM 366 2466-73 2012

Treatment for Erythema Migrans With Doxycycline for 10 Days Versus 15 Days

03.09.2012 (Constantine Bloch)
Stupica D. et al.: Treatment for Erythema Migrans With Doxycycline for 10 Days Versus 15 Days
Clin Infect Dis 55 (3) 343-50 2012

Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial

27.08.2012 (Stefan Erb)
Wong C. et al: Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial
Lancet 380 660-67 2012

Treatment of First Recurrence of Clostridium difficile Infection: Fidaxomicin Versus Vancomycin

13.08.12 (Barbara Jakopp)
Oliver A. Cornely: Treatment of First Recurrence of Clostridium difficile Infection: Fidaxomicin Versus Vancomycin
CID 55 154-161 2012

Isoniazid for preventing tuberculosis in non-HIV infected persons

06.08.2012 (Marcel Stöckle)
Smieja M.: Isoniazid for preventing tuberculosis in non-HIV infected persons
The Cochrane Library 2010, Issue 1 1 - 21 2010

Chlamydia trachomatis, Myoplasma genitalium and Trichomonas vaginalis Infections in Men with Nongonococcal Urethritis: Predictors and Persistence after Therapy

30.7.2012 (Bettina Khanlari)
Seña A et al.: Chlamydia trachomatis, Myoplasma genitalium and Trichomonas vaginalis Infections in Men with Nongonococcal Urethritis: Predictors and Persistence after Therapy
JID 206 357-365 2012

Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry Identification of Mycobacteria in Routine Clinical Practice

23.7.2012 (Daniel Goldenberger)
El Khéchine A et al.: Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry Identification of Mycobacteria in Routine Clinical Practice
Plos ONE 6 e24720 2011


Rabies postexposure prophylaxis in routine practice in view of the new Centers for Disease Control and Prevention and World Health Organization recommendations


16.07.2012 (Esther Künzli)
Uwanyiligira M. et al.: Rabies postexposure prophylaxis in routine practice in view of the new Centers for Disease Control and Prevention and World Health Organization recommendations
CID 5 201-205

Ciprofloxacin for 7 days versus 14 days in women with acute pyelonephritis the lancet

09.07.12 (Dominique Fasel)
Torsten Sandbert et al: Ciprofloxacin for 7 days versus 14 days in women with acute pyelonephritis the lancet
Online June 2012 1-7 2012

Delemanid for Multidrug-Resistant Pulmonary Tuberculosis

2.07 2012 (Adrian Schibli)
Gler et al.: Delemanid for Multidrug-Resistant Pulmonary Tuberculosis
NEJM 366 2151-2160 2012

Rates of Hospitalizations for Respiratory Syncytial Virus, Human Metapneumovirus, and Influenza Virus in Older Adults

01.07.2012 (Elisabeth Wehrle)
Widmer et al: Rates of Hospitalizations for Respiratory
Syncytial Virus, Human Metapneumovirus,
and Influenza Virus in Older Adults

JID 206 56-61 2012

High Dose, Extended-Interval Colistin Administration in Critically Ill Patients: Is this the Right Dosing Strategy? A Preliminary Study

04.06.2012 (Veronika Bättig)
Dalfino L. et al.: High Dose, Extended-Interval Colistin Administration in Critically Ill Patients: Is this the Right Dosing Strategy? A Preliminary Study
CID 54 1720-26 2012

Oral Fluoroquinolones and the Risk of Retinal Detachment

21.05.2012 (Esther Künzli)
Etminan M. et al.: Oral Fluoroquinolones and the Risk of Retinal Detachment
JAMA 307 1414-1419 2012

No Treatment versus 24 or 60 Weeks of Antiretroviral Treatment during Primary HIV Infection: The Randomized Primo-SHM Trial

07.05.2012 (Marcel Stöckle)
Grijsen M. Et al.: No Treatment versus 24 or 60 Weeks of Antiretroviral Treatment during Primary HIV Infection: The Randomized Primo-SHM Trial
PLoS Medicine 9 Issue 3 2012

Cefpodoxime vs Ciprofloxacin for Shourt-Course Treatment of Acute Uncomplicated Cystitis

30.04.12 (Dominique Fasel)
Thomas M. Hootom et al.: Cefpodoxime vs Ciprofloxacin for Shourt-Course Treatment of Acute Uncomplicated Cystitis
JAMA February 8, 2012-Vol 307, No 6. 583-589 2012

Screening for tuberculosis in asylum seekers: comparison of chest radiography with an interview-based system

23.04.2012 (Evelin Bucheli)
S. Schneeberger Geisler: Screening for tuberculosis in asylum seekers: comparison of chest radiography with an interview-based system
Int J Tuberc Lung Dis 14 1388-1394 2010

Administration of Voriconazole in patients with renal dysfunction

26.03.12 (Elisabeth Wehrle)
Neofytos et al. Administration of Voriconazole in patients with renal dysfunction
CID 54 913-921 2012

Long-Term Outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients

12.3.2012 (Nina Khanna)
Heslop H. et al. Long-Term Outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients
Blood 115 925-35 2010

Household Versus Individual Approaches to Eradication of Communitiy-Associated Staphylococcus aureus in Children: A Randomized Trial

05.03.2012 (Veronika Bättig)
Fritz et al. Household Versus Individual Approaches to Eradication of Communitiy-Associated Staphylococcus aureus in Children: A Randomized Trial
CID 54 743-51 2012

Host and Pathogen Factors for Clostridium difficile Infection and Colonisation

20.02.2012 (Esther Künzli)
Loo et al. Host and Pathogen Factors for Clostridium difficile Infection and Colonisation
NEJM 365 1693-703 2011

Schweizerischer Impfplan 2012

13.02.2012 (Marcel Stöckle)
Bundesamt für Gesundheit: Schweizerischer Impfplan 2012
BAG Bulletin 6 105-15 2012

Laminar Airflow Ceiling Size: No Impact on Infection Rates Following Hip and Knee Prosthesis

06.02.2012 (Evelin Bucheli)
Breier A. et al.:Laminar Airflow Ceiling Size: No Impact on Infection Rates Following Hip and Knee Prosthesis
Infect Conrtol Hosp Epidemiol 32 1097-1102

ß-Lactam/ß-Lactam Inhibitor Combinations for the Treatment of Bacteremia Due to Extended-Spectrum ß-Lactamase–producing Escherichia coli: A Post Hoc Analysis of Prospective Cohorts

30.01.2012 (Danielle Vuichard)
Jesús Rodríguez-Baño: ß-Lactam/ß-Lactam Inhibitor Combinations for the Treatment of Bacteremia Due to Extended-Spectrum ß-Lactamase–producing Escherichia coli: A Post Hoc Analysis of Prospective Cohorts
Clinical Infectious Diseases 54(2) 167–74 2012

Statins and prevention of infections: systematic review and meta-analysis of data from large randomised placebo controlled trials

23.01.2012 (D.Fasel)
Hester L van den Hoek: Statins and prevention of infections: systematic review and meta-analysis of data from large randomised placebo controlled trials
BMJ November 2011, 7830 1-10 2011

Outcomes of moderate to severe pneumocystis pneumonia treated with adjunctive steroid in non-HIV-infected patients

16.1.12 (Baharak Babouee)
Mi Moon et al.: Outcomes of moderate to severe pneumocystis pneumonia treated with adjunctive steroid in non-HIV-infected patients
Antimicrob Agents Chemother 55 1413-18 2011

Three Months of Rifapentine and Isoniazid for Latent Tuberculosis Infection

9.1.2012 (Stefan Erb)
Sterling et al.: Three Months of Rifapentine and Isoniazid for Latent Tuberculosis Infection
NEJM 23 2155-66 2011